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In Sweden, previous favourable trends in blood cholesterol levels have recently levelled off
or even increased in some age groups since 2003, potentially reflecting changing fashions
and attitudes towards dietary saturated fatty acids (SFA). We aimed to examine the poten-
tial effect of different SFA intake on future coronary heart disease (CHD) mortality in 2025.
Methods
We compared the effect on future CHD mortality of two different scenarios for fat intake a)
daily SFA intake decreasing to 10 energy percent (E%), and b) daily SFA intake rising to 20 E
%. We assumed that there would be moderate improvements in smoking (5%), salt intake
(1g/day) and physical inactivity (5% decrease) to continue recent, positive trends.
Results
In the baseline scenario which assumed that recent mortality declines continue, approxi-
mately 5,975 CHD deaths might occur in year 2025. Anticipated improvements in smoking,
dietary salt intake and physical activity, would result in some 380 (-6.4%) fewer deaths (235
in men and 145 in women). In combination with a mean SFA daily intake of 10 E%, a total of
810 (-14%) fewer deaths would occur in 2025 (535 in men and 275 in women). If the overall
consumption of SFA rose to 20 E%, the expected mortality decline would be wiped out and
approximately 20 (0.3%) additional deaths might occur.
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Conclusion
CHDmortality may increase as a result of unfavourable trends in diets rich in saturated fats
resulting in increases in blood cholesterol levels. These could cancel out the favourable
trends in salt intake, smoking and physical activity.
Introduction
Mortality from coronary heart disease (CHD) has decreased dramatically in Sweden and other
Western countries during recent decades [1]. Researchers in regions including Europe, the
United States, and New Zealand have used the previously validated IMPACT mortality model
to investigate these trends in many countries in Europe and elsewhere [2–7]. Briefly, the model
provides an estimate of the effect of changes in risk factors (e.g., smoking, total blood choles-
terol, systolic blood pressure (SBP), physical inactivity, diabetes, body mass index [BMI]) and
medical treatments and interventions on past trends in CHDmortality under given scenarios.
We can also use the IMPACT model to predict future trends in CHDmortality [8, 9].
Previously, we used the IMPACT model to investigate the decrease in CHDmortality in
Sweden between 1986 and 2002 in Sweden [10]. We demonstrated that CHD mortality in the
25–84 year age group decreased by 53.4% in men and by 52.0% in women, and that 13 180
fewer deaths occurred in 2002 than would have been expected if the CHDmortality rates from
1986 had persisted [10]. Based on the IMPACT model, we concluded that approximately one
third of the mortality decrease could be explained by increased use of effective medical treat-
ments and interventions, and more than half of the decrease could be explained by population-
level improvements in risk factors, particularly a decrease in total blood cholesterol levels
(from 6.1 mmol/L to 5.5 mmol/L) [10]. Population studies in the city of Gothenburg show that
total blood cholesterol levels in men have decreased from 6.5 mmol/L in 1973 [11] to 5.5
mmol/L in 2002 [10, 12] and in women from 7.4 mmol/L in 1969 [13] to 5.6 mmol/L in 2002
[12]. These decreases in total blood cholesterol likely reflected dietary changes, such as reduced
intake of saturated fat and altered fatty acid intake profile. Data for northern Sweden are simi-
lar, with a decrease in reported total blood cholesterol from 1986 to 1992 and, after a small
increase, a continued decline until 2002, followed by steady levels between 2002 and 2004 [14].
The relationship between diet and total blood cholesterol [15–18] as a major risk factor for
CHD is well known [19–21]. Therefore, there have been growing concerns over recent adverse
dietary trends in Sweden [14, 22]. However, the possible beneficial health effects of low carbo-
hydrate–high fat diets have been described in very positive terms by the Swedish media [23].
This media debate may have affected food selection among the population, with higher
reported intakes of cream, butter, butter-based spreads, and red meat, and lower reported
intakes of bread, cereals, and potatoes [14, 22]. Consequently, the reported dietary intake of
total fat and saturated fat in the population of northern Sweden has increased markedly since
2002, whereas carbohydrate intake has decreased [14]. In parallel, total blood cholesterol levels
have increased since 2003[14], interrupting and even reversing the trend to lower total blood
cholesterol levels observed in the 1980s and 1990s. These recent data suggest that a consider-
able change in dietary fat intake has occurred in the Swedish population since we last applied
the IMPACT model to predict CHDmortality based on life style risk factors [10].
In the present study we used the IMPACT model and Swedish lifestyle data to predict how
changes in fat intake might affect total blood cholesterol levels and CHDmortality in the Swed-
ish population between 2010 and 2025. We applied two contrasting scenarios for trends in die-
tary intake of total fat: lower saturated fat intake, which would be a reduction based on current
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PLOS ONE | DOI:10.1371/journal.pone.0160474 August 4, 2016 2 / 13
European Union Health Programme (Executive
Agency for Health & Consumers), “EuroHeart II”
(European Heart Health Strategy 2; ADONIS code A/
100946) provided additional funding for the study
methodology. The funders had no role in the study
design, data collection and analysis, decision to
publish, or preparation of the manuscript. MCG and
PB also received support from the National Institute
for Health Research’s School for Public Health
Research (NIHR SPHR).
Competing Interests: The authors have declared
that no competing interests exist.
population intake, in a diet based on the Nordic Nutrition Recommendations; and higher satu-
rated fat intake, compared to current population intake, in a low carbohydrate–high fat diet.
Methods
The IMPACTmodel
The IMPACT model was developed to explain changes in trends in CHDmortality in terms of
changes in CHD risk factors in the population, and changes in medical management and treat-
ment uptake. The model has been described in detail elsewhere [4, 24]. We used the IMPACT
model for the Swedish population aged 25–84 years to evaluate two scenarios with different
levels of saturated fat intake, and to compare the results against a baseline scenario where there
is no change in risk factors until 2025. The two scenarios were as follows:
1. a low saturated fat diet scenario with a decrease in intake of saturated fat equivalent to 10%
of total energy (10 E%), which adheres to the current Nordic Nutrition Recommendations
[25]; and
2. a high saturated fat intake scenario with an increase in intake of saturated fat equivalent to
20 E%, which aims to mimic recent dietary trends in northern Sweden, but corresponds to
the 95% percentile values in a recent nationwide survey of the Swedish diet [26].
In both scenarios, we assumed that recent positive trends in other major risk factors would
continue. That is, we assumed that by 2025 there would be a 10% (1 g/day) reduction in salt
intake, a 5% reduction in smoking, and a 5% decrease in physical inactivity in each 10-year age
group. The primary outcome measure was the decline in mortality in 2025 relative to 2010,
that is, the total number of deaths prevented or postponed as a result of changes in the risk fac-
tors in each scenario. The number of deaths prevented or postponed was defined as the differ-
ence between the number of deaths from CHD expected in 2025 and the number of deaths
from CHD observed in 2010.
Baseline scenario: estimating the expected number of deaths from CHD
in 2025
For the baseline scenario, we assumed that CHD mortality would continue to decline at the
same rate as that recorded for the past two decades. Therefore, we fitted a series of exponential
decay models to age-specific CHD mortality rates from 1986 to 2010. The rates were extrapo-
lated to 2025, and multiplied by the official population projections.
Modelling effects of risk factors
The IMPACT model considers SBP, total blood cholesterol, smoking, and physical inactivity as
risk factors for CHD mortality. To model the effect of saturated fat and salt intake on CHD
mortality, first we translated these factors into changes in total blood cholesterol and SBP,
respectively.
Translating changes in saturated fat intake into changes in cholesterol. We calculated
the effect of saturated fat intake on total blood cholesterol using the equations reported by
Clarke et al [27]. These equations were obtained from metaregression analysis of more than
90 metabolic ward studies, and translate a change in saturated fat intake into a change in total
blood cholesterol levels at an isocaloric replacement with polyunsaturated and monounsatu-
rated fats. A decrease in saturated fat intake of 1% corresponds to a decrease in total blood
cholesterol of 0.078 mmol/L or 0.048 mmol/L when replaced by polyunsaturated or monoun-
saturated fat, respectively. In the present model, we assumed that every percent unit of
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saturated fat intake was replaced by 90% polyunsaturated fat and 10% monounsaturated fat.
The analysis indicated that a decrease in saturated fat intake of 1% would result in a reduction
in total blood cholesterol of 0.3 mmol/L (i.e., (0.078 × 0.90) + (0.048 × 0.10); (http://www.
escardio.org/static_file/Escardio/EU-Affairs/chd-mortality.pdf). We assumed the effect to be
linear within the expected range of saturated fat intake (10–20 E%).
Translating changes in salt intake into changes in SBP. Wemodelled the link between
salt intake and blood pressure based on data from a Cochrane Database System Review [28].
According to this extensive metaregression, a 6 g/day reduction in salt intake would result in a
7.2 mm Hg reduction in SBP in people with hypertension, and a 3.6 mm Hg reduction in peo-
ple with normal blood pressure. In 2010 about 37% (weighted average) of the adult Swedish
population had hypertension, and we assumed this rate would remain constant for the forecast
period. The analysis indicated that a reduction in salt intake of 1 g/day (10%) would result in a
reduction in SBP of 0.82 mm Hg (i.e., [(7.2 × 0.37) + (3.6 × 0.63)]/6) across the adult Swedish
population.
Translating changes in risk factors into changes in CHDmortality. We used two
approaches to calculate the number of deaths prevented or postponed from changes in risk fac-
tors in the IMPACT model: the regression approach; and the change in the Population Attrib-
utable Risk Fraction (PARF). We used the regression approach for total blood cholesterol and
SBP. We multiplied the number of CHD deaths in 2010 by the absolute change in risk factor
level (defined below), and by an age and gender specific regression coefficient quantifying the
estimated relative change in CHDmortality that would result from a change in the risk factor
level of one unit (i.e., per 1 mm Hg change in SBP and per 1 mmol/L change in total blood cho-
lesterol (S1 and S2 Tables). We used the PARF for smoking and physical inactivity. We calcu-
lated the PARF, which reflects the reduction in mortality rate from CHD if exposure were
eliminated, according to the conventional formula: PARF = [P × (RR − 1)]/[1 + P × (RR − 1)]
where P is the age and gender-specific prevalence of the risk factor, and RR is the age and gen-
der-specific relative risk for CHD mortality associated with risk factor presence. We then esti-
mated the number of deaths prevented or postponed as the expected CHD deaths in 2025
multiplied by the difference in PARF for 2010 and 2025. Relative risks for smoking and physi-
cal inactivity are given in S3 Table and S4 Table, respectively. We rounded all values for the
number of deaths prevented or postponed to the nearest 5.
Sensitivity analyses
We quantified the degree of stochastic uncertainty using Monte Carlo simulation implemented
with R software. We repeated random draws from specified distributions for the input variables
(S5 Table) to iteratively recalculate the model. We calculated the uncertainty intervals based on
10 000 draws taking the 95% uncertainty intervals as the 2.5th and 97.5th percentiles. We ran-
domly extracted input variables taken from external sources (e.g., beta coefficients and relative
risk reductions) from specified distributions. Specific distributions used in our analysis are pre-
sented in S5 Table. Furthermore, we investigated the sensitivity in the saturated fat intake pro-
jections by comparing the effect of changes in saturated fat intake by -5, -10, +5 and +10 E%
from current levels stratified by age group and sex (S6 Table).
Data collection and sources
Population data. We obtained population numbers for each 10-year age group (25–84),
stratified by sex, for both the baseline (2010) and prediction (2025) years from the national
database (Statistics Sweden). We retrieved mortality data for 2010 from the Swedish National
Board of Health and Welfare.
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Population risk factors. We obtained data on measured total blood cholesterol and SBP
from the northern SwedenMONICA study and the Prospective Urban and Rural Epidemiologi-
cal (PURE) Study, Gothenburg (2007–2009). We obtained data on smoking and physical activity
from Living Conditions Surveys (ULF), Statistics Sweden (2010). For the analyses, we calculated
total blood cholesterol and SBP by weighting the data from northern Sweden (MONICA; 15%)
and southern Sweden (PURE; 85%) to reflect the national population distribution. We expressed
the data as population mean values within each 10-year age group and sex. Detailed information
on data sources, including data for 1986 and 2002, is summarized in Table 1.
Dietary intake. Dietary intake data from the Västerbotten Intervention Programme (VIP)
and the northern Sweden MONICA project are combined in the Northern Sweden Diet Data-
base (NSDD) (http://www.biobank.umu.se/biobank/biobank—for-researchers/northern-
sweden-diet-database/). A semiquantitative food frequency questionnaire (FFQ) was used to
estimate food intake with a 9-level fixed scale from never to4 times per day, and portion
sizes are estimated from photographs of staple foods such as meat, fish, and vegetables. We
transformed reported intake frequencies into intake per day, and estimated energy and nutrient
intake by weighting reported intake frequencies with portion sizes and nutrient content
obtained from the database at the National Food Administration, Sweden (www.slv.se). Nutri-
ent data included the intake of total fat, saturated fat, and monounsaturated and polyunsatu-
rated fat expressed as the E% (S7 Table). We obtained data on salt intake from a national
population-based study on dietary intake (Riksmaten [The National Diet] 2010–2011) per-
formed by the Swedish National Food Agency in 1 800 randomly selected adults [26]. The esti-
mated mean intake of salt was 10 g/day across all age groups and for both sexes.
Results
Trends in risk factors used in the IMPACT model for the period 1986–
2010
Based on the information from the MONICA and PURE studies, physical activity improved,
and total blood cholesterol fell in Sweden from 1986 to 2002. However, diabetes prevalence
Table 1. Data sources for population and risk factor estimations.
Type of data Source
Population numbers 2010 Statistics Sweden





Risk Factor Levels in 1986 The AMORIS Study (total blood cholesterol), MONICA GOT and Northern
Sweden (SBP, hypertension), ULF, Statistics Sweden (smoking, BMI,
diabetes and physical inactivity)
Risk Factor Levels in 2002 MONICA GOT and Northern Sweden, INTERGENE (total blood cholesterol,
hypertension), MONICA Northern Sweden and INTERGENE Study, the
Prospective Population Study of Women in Goteborg (SBP), ULF, Statistics
Sweden (smoking, BMI, diabetes and physical inactivity)
Risk Factor Levels in 2010 MONICA Northern Sweden and the PURE* study, Gothenburg (2007–2009)
(total blood cholesterol and SBP), ULF**, Statistics Sweden (smoking, BMI
and physical inactivity), VEGA database*** (diabetes)
*Prospective Urban and Rural Epidemiological Study
**Living Conditions Surveys
*** Västra Götalands Vårddatabas.
doi:10.1371/journal.pone.0160474.t001
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and BMI increased (Table 2). In 2010, total blood cholesterol levels were similar to those in
2002, whereas SBP, diabetes prevalence, and BMI had all increased. Smoking prevalence fell
progressively from 1986 to 2010. The percentage of people who were physically inactive was
slightly higher in 2010 than in 2002. Risk factors by age and sex for 2010 are shown in Table 3.
Population trends in reported dietary fat intake for the period 1986–2013
Information from the NSDD revealed that the intake of total fat (saturated fat, monounsatu-
rated fat, and polyunsaturated fat) increased by 5 E% from 34.0 E% in 2002–2004 to 39.1 E% in
2011–2013. During the same period, the intake of saturated fat increased from 14.0 E% to 16.7
Table 2. Risk factors in Swedishmen and women in 1986, 2002, and 2010.
Year
Risk Factor 1986 2002 2010
Men
Mean total blood cholesterol (mmol/L) 6.15 5.51 5.48
Smoking prevalence (%) 31.3 17.6 13.2
Mean SBP (mm Hg) 135.0 132.9 134.3
Diabetes prevalence (%) 2.8 4.2 6.7
Mean BMI (kg/m2) 24.8* 26.0 26.3
Physical inactivity prevalence* (%) 15.9 12.7 17.3**
Women
Mean total blood cholesterol (mmol/L) 6.19 5.51 5.53
Smoking prevalence (%) 26.6 19.5 15.2
Mean SBP (mm Hg) 132.7 129.7 130.8
Diabetes prevalence (%) 2.5 3.4 5.1
Mean BMI (kg/m2) 23.8* 24.8 24.9
Physical inactivity prevalence* (%) 15.6 10.4 12.0**
*1988
**Method change in 2008.
doi:10.1371/journal.pone.0160474.t002
Table 3. Risk factors in Swedishmen and women in 2010, presented by age group.
Age group
25–34 35–44 45–54 55–64 65–74 75–84
Men
Mean total blood cholesterol (mmol/L) 4.98 5.36 5.48 5.56 5.57 5.48
Smoking prevalence (%) 11.8 10.5 13.8 18.1 15.8 6.0
Mean SBP (mm Hg) 125.9 126.4 131.7 139.2 145.4 151.3
Diabetes prevalence (%) 0.9 1.8 4.3 9.4 15.2 18.0
Mean BMI (kg/m2) 25.5 26.7 26.7 26.6 26.5 25.6
Physical inactivity prevalence (%) 11.4 20.0 19.7 18.7 14.8 20.9
Women
Mean total blood cholesterol (mmol/L) 4.66 4.92 5.51 5.51 5.8 5.68
Smoking prevalence (%) 11.3 14.3 24.2 16.7 13.3 6.3
Mean SBP (mm Hg) 118.3 119.1 126.5 136.9 144.2 153.3
Diabetes prevalence (%) 0.8 1.4 2.9 5.9 10.4 14.1
Mean BMI (kg/m2) 23.6 24.5 25.4 25.3 25.8 25.2
Physical inactivity prevalence (%) 9.0 12.8 10.6 9.9 12.0 23.3
doi:10.1371/journal.pone.0160474.t003
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E%, reflecting increased intake of butter and butter-based spreads, dairy products (cream/
crème fraîche), red meat, bacon, and sausages. Butter and butter-based spreads contributed
most to the increase in saturated fat intake, increasing from 8.5 E% to 12.9 E%; S7 Table). Fig 1
shows changes in saturated fat intake for men and women in 10-year age groups. In the period
from 1995 to 2004, the saturated fat intake (E%) stayed at a fairly constant level of about 15 E%
and 13 E%, respectively, in men in women overall, and about 17.5 E% and 15.5 E%, respec-
tively, in young men and women aged 25–34 years (Fig 1). However, between 2005 and 2010,
the intake of saturated fat, monounsaturated fat, polyunsaturated fat, and total fat increased in
both sexes, but more so in men than in women (S7 Table).
Prediction of CHD deaths in 2025 based on different lifestyle scenarios
In the baseline scenario (with no estimated change in risk factors), which assumes that recent
CHDmortality trends continue, we estimated that about 5 975 CHD deaths might occur in
2025 (4 010 in men and 1 965 in women). This would be 46% lower than the 11 000 deaths
expected if the current CHD mortality rates were to remain constant. CHDmortality rates by
age and sex for 2010 and 2025 are summarized in S8 Table.
Low saturated fat diet scenario with 10 E%. With the low saturated fat diet scenario, a
total of 810 (-14%) (minimum estimate 665, maximum estimate 955) deaths could be pre-
vented or postponed in 2025 (535 in men and 275 in women; Fig 2). A reduction of saturated
fat intake to 10 E% would result in a reduction in total blood cholesterol of 0.44 mmol/L in
men and 0.33 mmol/L in women, and would prevent or postpone approximately 300 deaths in
men (minimum estimate 230, maximum estimate 370) and 130 deaths in women (minimum
estimate 100, maximum estimate 165). Salt reduction would prevent or postpone 90 deaths in
men (minimum estimate 65, maximum estimate 115) and 50 deaths in women (minimum esti-
mate 35, maximum estimate 70). Reduction in smoking might prevent or postpone 90 deaths
in men (minimum estimate 40, maximum estimate 140) and 60 deaths in women (minimum
estimate 30, maximum estimate 100). Decreases in physical inactivity might prevent or post-
pone 60 deaths in men (minimum estimate 20, maximum estimate 100) and 30 deaths in
women (minimum estimate 10 maximum estimate 50). The number of deaths prevented or
postponed according to the four factors, stratified by age and sex, are summarized in Fig 2 and
S9 Table.
Fig 1. Saturated fat intake in Sweden (1986–2013) by age group and sex. Since 2002–2004 the amount of energy coming from saturated fat as
increased in all age groups and in both men (A) and women (B).
doi:10.1371/journal.pone.0160474.g001
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High fat scenario with 20 E% saturated fat. In the high fat scenario, the increased intake
of saturated fat would increase total blood cholesterol levels by 0.19 mmol/L in men and by
0.30 mmol/L in women, and result in approximately 400 (+6.7%) additional deaths in 2025.
This would represent about 230 additional deaths in men (minimum estimate 175, maximum
estimate 285) and 175 additional deaths in women (minimum estimate 130, maximum esti-
mate 220). However, some of these additional deaths would be negated by improvements in
other risk factors. Therefore, overall deaths might increase by 20 (minimum estimate −115,
maximum estimate 60). There would be about 10 fewer deaths in men (minimum estimate
−65, maximum estimate 80) and about 30 additional deaths in women (minimum estimate
−85, maximum estimate 15). Reductions in salt, smoking, and physical inactivity might prevent
or postpone about 430 (-7.2%) deaths in total (290 deaths in men and 140 in women). Age and
sex stratified data for the number of deaths prevented or postponed according to the four fac-
tors are summarized in Fig 2 and S9 Table.
Sensitivity analysis. In addition to the two scenarios we also compared the effect of abso-
lute changes in saturated fat intake by -10, -5, +5 and +10 E% from current intake as summa-
rized in S6 Table.
Discussion
Since the 1980s, CHDmortality in Sweden has decreased dramatically, largely reflecting
improvements in population risk factors. Changes in diet can powerfully modify total blood
cholesterol and blood pressure, two major risk factors for CHD. We developed a model that
allowed us to quantify such changes in terms of deaths prevented or postponed. We compared
two plausible scenarios: a low diet with just 10 E% from saturated fat (reflecting the Nordic
Nutrition Recommendations); and a high fat diet with 20 E% from saturated fat (reflecting
recent popular dietary trends, and an increase from the 2010 values of about 17%; Fig 1). We
Fig 2. Predicted number of deaths that could be prevented or postponed in men and women from 2010 to 2025 for two diet scenarios. Both
scenarios included a reduction in salt intake by 10% and an absolute decrease in physical inactivity and smoking by 5%. Numbers are rounded to nearest 5.
doi:10.1371/journal.pone.0160474.g002
Saturated Fat and CHDMortality
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found that adherence to the recommended, lower fat diet would substantially reduce CHD
mortality, while the higher fat diet would actually increase the number of CHD deaths.
Trends in total blood cholesterol levels reflect population diet quality. Recent data indicate
that the consumption of saturated fat has increased since the mid-2000s, deteriorating to intake
levels similar to 1986. If these adverse trends continue, the benefits from continued reductions in
smoking and salt intake could be wiped out, with CHDmortality rates levelling off or even
increasing in some age groups. The relationship between population total blood cholesterol levels
and CHDmortality is well known. However, the powerful roles of “good” and “bad” dietary fats
are less well appreciated. In Sweden, there has been a recent increase in the intake of products
rich in saturated fat, such as cream, butter, and red meat, with the saturated fat intake rising
towards the 20 E% level. This has led to higher total blood cholesterol levels in the population. As
seen in Fig 1, consumption of saturated fat in the Västerbotten cohort in 2013 had increased
compared with a decade earlier and was close to 20 E% in some age groups (e.g., young men).
In the present study, we particularly focused on one specific risk factor for CHD, dietary sat-
urated fat, and investigated how corresponding changes in blood total blood cholesterol might
affect future CHDmortality. We used the previously developed IMPACT model to predict
changes in future CHDmortality between 2010 and 2025 in the projected Swedish population
aged 25–84. We assumed that the other major risk factors for CHD might continue to improve
in line with recent beneficial trends, so that salt intake would fall from 10 g/day to 9 g/day,
smoking prevalence would fall from 13% to 8% in men and from 15% to 10% in women, and
physical inactivity would decrease from 12% to 7% in men and from 17% to 12% in women.
The Swedish diet has traditionally been high in salt intake [26] with correspondingly high
blood pressure levels and more than 25% of the adult population are hypertensive [29]. Reducing
salt intake is important from a population perspective, and even a modest reduction of 1 g/day
would lead to a considerable decrease in SBP in the population [28]. Furthermore, a 20 mmHg
decrease in SBP is associated with a halving of deaths from stroke and CHD [30, 31]. Even a
rather moderate and eminently feasible decrease in salt intake of 1 gram per day would be power-
ful. Sadly, at present Sweden has no legislation to restrict salt content in food. Conversely, the
recent successful salt reduction programme in the United Kingdom decreased consumption by
15%, potentially preventing between 5 000 and 10 000 deaths [32, 33]. We assumed that absolute
smoking prevalence would decrease by 5%. Smoking has decreased continuously among the
Swedish population since the 1980s. Moreover, a smoking ban in public places was introduced in
2005 and further restrictions in public places are planned. Physical inactivity is an increasing
population problem, potentially leading to increased prevalence of overweight, obesity and diabe-
tes. However, awareness of the problem has increased and a 5% decrease in physical inactivity
would be achievable through effective, population-wide policies [34–36].
The link between saturated fat intake and CHDmortality remains poorly understood. A
recent meta-analysis showed no association between saturated fat and total CHD and a trend
for CHDmortality, when results were adjusted for any confounders including LDL cholesterol.
However, with a more parsimonious model, that did not include LDL, saturated fat intake was
significantly associated with both total CHD and CHDmortality [37]. In addition a large
meta-analysis showed a significant effect of reducing saturated fat and/or modifying dietary fat
composition on cardiovascular events but not on mortality. The reduction in event was related
to the change in total and LDL cholesterol [38].
A recent study from the British Isles used the IMPACT model to project the future CHD
mortality assuming that the recent declining trends would continue. One scenario assumed
“ideal” improvements in risk factors such as smoking and physical inactivity would decrease by
15% and the intake of dietary salt intake and saturated fat intake up to 30% and to 6% respec-
tively. A second, “modest” scenario assumed absolute reductions in smoking and physical
Saturated Fat and CHDMortality
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activity by 5% and the intake of dietary salt by 10% intake and a reduction in daily saturated fat
intake up to 2 E%. The study showed that achievable reductions in cardiovascular risk factors
significantly could reduce the future CHDmortality. Reductions in smoking could decrease
CHD deaths by 5.8–7.2%, reductions in physical inactivity by 3.1–3.6% and reductions in salt
intake by some 5.2–5.6% while reduction in saturated fat intake would decrease CHD deaths
by 7.8–9.0% [9].
However, projections are dependent on the actual risk factor levels. For instance, Sweden
has relatively few smokers in the population, with a prevalence of 13.2%. Accordingly we
assumed that a 5% absolute reduction in smoking prevalence would be feasible, in contrast to a
15% reduction in the study by Hughes et al [9]. Concerning the saturated fat intake we assumed
a daily intake of 10 E% which is according to the Nordic Nutrition Recommendations (low sat-
urated fat intake) [25]. However, current trends show an increasing intake of saturated fat (Fig
1) and accordingly we also projected future CHDmortality based on a high saturated fat intake
(20 E%) and changes in risk factors as described above.
The trends in CHDmortality are largely similar in most Western countries, but there are
some differences [1]. In particular, trends among younger people show large differences
between countries [39–41]. Furthermore, there are differences in smoking, physical inactivity
and dietary patterns between countries. In conclusion, models and projections needs to devel-
oped and adapted to the specific conditions in the country under study.
Strengths and limitations
Modelling studies have a number of potential strengths. The best models can integrate and
simultaneously analyse huge amounts of data from many sources. However, models are depen-
dent on the extent and quality of the available data. To ensure representativeness all data used
in the present study were from Swedish sources such as population studies, national surveys
(Statistics Sweden), and governmental reports. In addition, representative data for population
risk factors in 1986, 2002, and 2010 were obtained from different parts of Sweden to minimize
possible geographical variations, and the data were weighted by population size for sex and for
different age groups.
Differences between the periods for diagnostic criteria and the quality of recorded causes of
death present a potential limitation to the present study. However, standardized data from
population and hospital discharge registries in Sweden are highly accurate and almost 100%
complete [42, 39]. The core of the present model was the IMPACT model, which has been vali-
dated in a large number of countries [2–7, 10]. The link between changes in lifestyle and
changes in risk factors was modelled using data from large meta-analyses of experimental and
observational studies. A potential limitation is that the models not directly take into account
trends in BMI and diabetes, however by using recent CHD trend data we have indirectly taken
into count adverse trends in BMI and diabetes.
We hypothesized that saturated fat would be replaced by polyunsaturated fat (90%) and
monounsaturated fat (10%). The change in total blood cholesterol by replacement of saturated
fat by polyunsaturated and monounsaturated fat was calculated from a total of 395 analyses on
solid food using crossover, parallel, Latin square, and sequential designs [27]. All our assump-
tions were tested in rigorous sensitivity analyses, which produced reassuringly consistent results.
Conclusions
An increase in saturated fat intake (up to 20% SFA daily) would increase the total blood choles-
terol levels and cancel out the positive effects on CHDmortality from predicted decreases in
salt intake, smoking, and physical inactivity. Conversely, small and readily achievable beneficial
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dietary changes could substantially reduce CHDmortality. Furthermore, substituting “bad”
saturated fat (mostly animal), with “good”monounsaturated and polyunsaturated fats (e.g.,
olive, sunflower, and canola oil) is eminently feasible.
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